Frontiers in Oncology | Pharmacology of Anti-Cancer Drugs

Editorial

Published on 17 Jul 2025

Editorial: Safety consideration in the development of anti-tumor monoclonal antibodies during drug development

in Pharmacology of Anti-Cancer Drugs

Tao Wang
Shaad Essa Abedin
Jan Willem van der Laan

Frontiers in Oncology

doi 10.3389/fonc.2025.1640377

331 views

Original Research

Published on 17 Jul 2025

Immune checkpoint inhibitor-associated autoimmune encephalitis and other neurological immune-mediated adverse events: a pharmacovigilance study using the FAERS and JADER

in Pharmacology of Anti-Cancer Drugs

Xiaomeng Di
Xiaohong Shi
Feng Gai
Jiawei Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1621045

258 views

Systematic Review

Published on 17 Jul 2025

A bibliometric and visual analysis of Jak1 to explore trends and frontiers

in Pharmacology of Anti-Cancer Drugs

Cong Yu
Jiamin Cao
Xiaodong Xie
Wenguang Chen
Ensi Hong

Frontiers in Oncology

doi 10.3389/fonc.2025.1537508

218 views

Original Research

Published on 16 Jul 2025

Utilization of dexrazoxane in patients treated with doxorubicin: a retrospective, propensity matched analysis of cardiac function and toxicity

in Pharmacology of Anti-Cancer Drugs

Zachary M. Neiman
Carlo S. Legasto
Alan K. Chin
Tiffany Guan
Brian C. Schulte

Frontiers in Oncology

doi 10.3389/fonc.2025.1621409

265 views

Review

Published on 16 Jul 2025

M6A RNA modification: focusing on non-small cell lung cancer progression, therapeutic strategies and challenges

in Pharmacology of Anti-Cancer Drugs

Yuyang Yan
Jiarui Yin
Quan Ding
Yan Lu
Shuhua Gou
Xi Xu
Yulin Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1622359

284 views

Review

Accepted on 14 Jul 2025

cGAS-STING signal status after EGFR-TKIs resistance in Non-Small Cell Lung Cancer

in Pharmacology of Anti-Cancer Drugs

Fang Hao

Frontiers in Oncology

doi 10.3389/fonc.2025.1643349

227 views

Original Research

Accepted on 14 Jul 2025

Microvascular endothelial cells PD-L1 expression predicts the efficacy and side effects of anlotinib

in Pharmacology of Anti-Cancer Drugs

Yingfang Feng
Yuan Gao
Shaochuan Liu
Tingting Qin
Yan Zhang
Jing Wang
Kai Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1544278

199 views

Original Research

Accepted on 14 Jul 2025

Integrating Network Pharmacology and Transcriptomics to Identify Solasonine's Anti-Osteosarcoma Targets and Experimental Validation

in Pharmacology of Anti-Cancer Drugs

Daihao Wei
Minyu Li
Dawei Chu
Jiandang Shi

Frontiers in Oncology

doi 10.3389/fonc.2025.1614058

Original Research

Published on 11 Jul 2025

AMPs inhibit the proliferation, migration, and invasion of lung cancer via the CHRM3/PI3K/AKT and CHRM3/MAPK pathways

in Pharmacology of Anti-Cancer Drugs

Jun Wu
Congcong Huang
Shangning Wang
Liuyan Chen
Quan Cheng
Shao Zhang

Frontiers in Oncology

doi 10.3389/fonc.2025.1582040

399 views

Review

Accepted on 08 Jul 2025

Synergistic Strategies in Photodynamic Combination Therapy for Cancer: Mechanisms, Nanotechnology, and Clinical Translation

in Pharmacology of Anti-Cancer Drugs

Fang Xie
Daohong Kan
Rong Ding
Huchuan Yang
Yuming Jia
Kaijian Lei
Zhongming Wang
Wei Zhang
Chaokun Yang
Zongjunlin Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1607259

Original Research

Published on 08 Jul 2025

Cell-in-cell associated lncRNA signature predicts prognosis and immunotherapy response in gastric cancer

in Pharmacology of Anti-Cancer Drugs

Junzuo Lin
Liancheng Wu
Zhengfei Zhao

Frontiers in Oncology

doi 10.3389/fonc.2025.1597187

371 views

Original Research

Published on 18 Jun 2025

The anti-inflammatory effects of oridonin in resisting esophageal cancer

in Pharmacology of Anti-Cancer Drugs

Mengfan Peng
Xiaofang Zhang
Lei Yang
Baosong Liu

Frontiers in Oncology

doi 10.3389/fonc.2025.1585057

895 views

Review

Published on 18 Jun 2025

Aberrant angiogenic signaling in HCC: therapeutic targeting and drug resistance

in Pharmacology of Anti-Cancer Drugs

Hongtao Zhang
Zhaoming Yang
Zhengwu Jiang
Zhijian Zhao
Xun Chen
Jian Wan
Yukun Li

Frontiers in Oncology

doi 10.3389/fonc.2025.1595195

863 views

Original Research

Published on 12 Jun 2025

Synergistic effects of 5-fluorouracil in combination with salinomycin promoted ferroptosis via inhibiting SLC7A11/GPX4 in colorectal cancer

in Pharmacology of Anti-Cancer Drugs

Can Wang
Junyang Wang
Fei Xing
Ning Liu
Xudong Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1558290

1,092 views

Clinical Trial

Published on 10 Jun 2025

Clinical outcomes of DNA-damaging agents and DNA damage response inhibitors combinations in cancer: a data-driven review

in Pharmacology of Anti-Cancer Drugs

Rick Fontenot
Neha Biyani
Kishor Bhatia
Reggie Ewesuedo
Marc Chamberlain
Panna Sharma

Frontiers in Oncology

doi 10.3389/fonc.2025.1577468

1,199 views

Original Research

Published on 06 Jun 2025

Interrogation of macrophage-related prognostic signatures reveals a potential immune-mediated therapy strategy by histone deacetylase inhibition in glioma

in Pharmacology of Anti-Cancer Drugs

Xisen Wang
Xuya Wang
Lei Chen
Haozhe Ding
Jikang Fan
Jianshen Liang
Yu Zhang
Yiming Li
Yiming Zhang
Shengping Yu

Frontiers in Oncology

doi 10.3389/fonc.2025.1554845

1,597 views